Medical Marijuana UK: Laws, NHS Guidance, Research and Safety
A comprehensive educational introduction to medical marijuana in the United Kingdom, including cannabis-based medicines, prescribing regulations, clinical evidence, health considerations and common misconceptions.
Updated: October 2026
What Is Medical Marijuana?
Medical marijuana is an informal expression used to describe cannabis-based substances used for medical purposes.
In UK healthcare and regulatory settings, the preferred terminology is generally medical cannabis or cannabis-based products for medicinal use.
These products may contain different cannabinoids, including tetrahydrocannabinol (THC) and cannabidiol (CBD).
Medical cannabis is not a single medicine. Different preparations have different chemical compositions, clinical applications and regulatory requirements.
The distinction matters because evidence supporting one specific prescription medicine cannot automatically be applied to every cannabis-containing product.
Is Medical Marijuana Legal in the UK?
In November 2018, UK regulations changed to permit certain cannabis-based products for medicinal use under defined prescribing conditions.
The regulatory change did not legalise recreational cannabis.
Cannabis remains a Class B controlled drug under the Misuse of Drugs Act 1971.
Unauthorised possession and supply remain subject to criminal law.
The legal medical framework applies to qualifying medicines and prescriptions, rather than to all products described as cannabis or marijuana.
Medical Marijuana vs Recreational Cannabis
| Characteristic | Medical Cannabis | Recreational Cannabis |
|---|---|---|
| Purpose | Clinical treatment under defined conditions | Non-medical use |
| UK legal status | Permitted under applicable medical regulations | Unauthorised possession and supply remain unlawful |
| Clinical oversight | Required according to prescribing rules | Not part of regulated treatment |
| Evidence | Varies by medicine and indication | Marketing claims do not establish clinical effectiveness |
| Quality regulation | Subject to applicable medicines requirements | Unregulated composition may be uncertain |
Understanding THC and CBD
Two of the most widely discussed cannabinoids are THC and CBD.
THC
Tetrahydrocannabinol is a psychoactive cannabinoid associated with cannabis.
It can influence attention, memory, perception, coordination and judgement.
THC can also cause adverse psychological effects and impairment.
CBD
Cannabidiol does not typically produce the same intoxicating effects as THC.
However, CBD is biologically active and may cause side effects or interact with other medicines.
Certain prescription cannabidiol medicines have recognised applications for specific severe epilepsy syndromes.
For further scientific context, read THC vs CBD: Key Differences.
Medical Cannabis and the NHS
Medical cannabis prescribing through the NHS remains limited.
The NHS explains that only a relatively small number of patients are likely to receive cannabis-based medicines through NHS services.
Relevant clinical circumstances include certain rare and severe epilepsy syndromes, chemotherapy-related nausea and vomiting, and selected cases of multiple sclerosis-related spasticity.
These circumstances do not amount to broad approval of all cannabis products for medical treatment.
The decision depends on the specific medicine, the patient's medical condition and the available evidence.
Recognised Cannabinoid Medicines
Epidyolex
Epidyolex is a prescription cannabidiol medicine used for particular severe epilepsy syndromes.
Its use requires appropriate clinical assessment and monitoring.
Sativex
Sativex is an oromucosal spray containing THC and CBD.
NICE recommends a defined trial for selected adults with moderate to severe multiple sclerosis-related spasticity when other medicines have not been effective.
Nabilone
Nabilone is a synthetic cannabinoid medicine.
NICE recommends considering it as an additional treatment for adults with persistent chemotherapy-induced nausea and vomiting despite optimised conventional treatment.
Why Medicine-Specific Evidence Matters
Clinical recommendations concern particular medicines and conditions. Evidence supporting a licensed cannabinoid medicine does not establish that ordinary cannabis products have the same benefits.
Medical Marijuana and Chronic Pain
Chronic pain is frequently discussed in medical cannabis research.
However, the available evidence does not support broad claims about effectiveness.
NICE guideline NG144 recommends against offering THC, nabilone, dronabinol or THC:CBD combinations for chronic pain in adults.
NICE also recommends against offering CBD for chronic pain outside a clinical trial.
These recommendations illustrate the importance of distinguishing between research interest and established clinical practice.
Medical Cannabis and Epilepsy
Certain severe epilepsy syndromes are among the conditions for which specific cannabinoid medicines have demonstrated clinical benefits.
Prescription cannabidiol medicines may be used under defined conditions with specialist supervision.
This does not establish that ordinary cannabis oils or commercial CBD products are equivalent treatments.
Medical Cannabis and Multiple Sclerosis
Multiple sclerosis affects the central nervous system and can cause symptoms including muscle stiffness and involuntary spasms.
Certain THC:CBD medicines have been studied for multiple sclerosis-related spasticity.
NICE provides specific recommendations for selected patients when other pharmacological treatments have not been effective.
Potential Side Effects
Cannabis-based medicines can cause adverse effects, like other medicines.
Drowsiness and Dizziness
Some preparations may cause sedation, dizziness or reduced alertness.
Psychological Effects
THC-containing medicines may affect mood, perception and concentration.
Medicine Interactions
Cannabinoids may interact with other prescribed medicines.
Liver-Related Concerns
Certain cannabidiol medicines may affect liver function, making clinical monitoring important.
Dependence
THC-containing preparations can present dependence and misuse concerns.
Medical Marijuana and Young People
Additional caution is necessary when considering cannabinoid medicines for children and adolescents.
The developing brain may be particularly vulnerable to psychoactive substances.
NICE advises clinicians to consider cognitive, psychological and neurological development when evaluating treatment for young patients.
Any appropriate treatment requires specialist medical supervision.
Medical Cannabis and Pregnancy
Cannabis exposure during pregnancy and breastfeeding raises important safety concerns.
Evidence about many cannabinoid preparations remains incomplete.
Patients should discuss potential risks and alternative treatments with qualified healthcare professionals.
Medical Cannabis and Driving
Some cannabinoid medicines can affect concentration, coordination and reaction time.
These effects are relevant to driving and other safety-sensitive activities.
Patients prescribed cannabinoid medicines should discuss potential impairment and relevant legal requirements with their medical team.
Common Myths About Medical Marijuana
Myth: All Cannabis Is Legal for Medical Use
UK law permits certain medical uses under defined conditions.
Myth: Every Cannabis Product Is a Medicine
A product containing cannabinoids is not automatically an authorised medicine.
Myth: Natural Products Have No Risks
Naturally occurring compounds can cause significant adverse effects and medicine interactions.
Myth: Medical Cannabis Is Proven for Every Condition
Clinical evidence varies considerably between conditions and medicines.
Myth: Online Availability Proves Legality
The appearance of a cannabis product on a website does not establish that its possession or supply is lawful.
Key Medical and Legal Takeaway
Medical cannabis is regulated in the UK, and only certain cannabis-based medicines can be prescribed under specific conditions.
Clinical evidence, individual health risks and professional medical oversight are essential to responsible treatment decisions.
Frequently Asked Questions
Is medical marijuana legal in the UK?
Certain cannabis-based medicines are legal under defined prescribing and regulatory conditions. Recreational cannabis remains controlled.
Is medical marijuana available through the NHS?
Certain cannabinoid medicines may be prescribed through NHS services for specific clinical indications. Availability remains limited.
Is medical marijuana the same as CBD?
No. Medical cannabis is a broad category that may include THC, CBD and other cannabinoids.
Can medical cannabis treat chronic pain?
NICE does not recommend the specified cannabinoid medicines for routine management of chronic pain in adults.
Can medical cannabis cause side effects?
Yes. Potential adverse effects include dizziness, sedation, cognitive effects and medicine interactions.
Are all cannabis oils medical products?
No. A product described as cannabis oil is not automatically an authorised medicine.
Is medical cannabis safe for children?
Certain specific medicines may be used for particular paediatric conditions under specialist supervision. Cannabis products are not generally safe for children.
Conclusion
Medical marijuana in the UK is best understood through the framework of regulated cannabis-based medicines.
Although certain cannabinoid medicines have recognised clinical applications, evidence varies substantially between medical conditions.
The legal medical framework does not extend to unrestricted recreational cannabis use.
Reliable information should come from the NHS, NICE, qualified healthcare professionals and official regulatory guidance.